Qurient Co., Ltd. (KOSDAQ:115180)
25,400
-1,550 (-5.75%)
At close: Jun 12, 2026
Qurient Market Cap
Qurient has a market cap or net worth of 1.03 trillion as of June 12, 2026. Its market cap has increased by 142.13% in one year.
Market Cap
1.03T
Enterprise Value
1.01T
Revenue
7.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,400.00
Market Cap Chart
Since February 29, 2016, Qurient's market cap has increased from 281.86B to 1.03T, an increase of 266.45%. That is a compound annual growth rate of 13.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.03T | -12.86% |
| Dec 30, 2025 | 1.19T | 674.51% |
| Dec 30, 2024 | 153.05B | 69.38% |
| Dec 28, 2023 | 90.36B | -24.77% |
| Dec 29, 2022 | 120.11B | -63.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.76T |
| Rznomics | 1.29T |
| JS Link | 1.14T |
| AprilBio | 970.50B |
| ROKIT Healthcare | 832.59B |
| Inventage Lab | 595.49B |
| Curocell | 438.51B |
| IMBiologics | 413.77B |